These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37681998)

  • 21. Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study).
    Solberg IC; Høivik ML; Cvancarova M; Moum B;
    Scand J Gastroenterol; 2015; 50(12):1456-62. PubMed ID: 26139389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis.
    Dalal R; Mitri J; Goodrick H; Allegretti J
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S19. PubMed ID: 37461990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
    Am J Gastroenterol; 2016 Nov; 111(11):1614-1620. PubMed ID: 27725646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
    Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin as a prognostic marker for ulcerative colitis.
    Khan N; Patel D; Shah Y; Trivedi C; Yang YX
    World J Gastroenterol; 2017 Dec; 23(45):8008-8016. PubMed ID: 29259376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Therapeutic Strategies Are Associated With a Significant Decrease in Colectomy Rate in Pediatric Ulcerative Colitis.
    Ley D; Leroyer A; Dupont C; Sarter H; Bertrand V; Spyckerelle C; Guillon N; Wils P; Savoye G; Turck D; Gower-Rousseau C; Fumery M;
    Am J Gastroenterol; 2023 Nov; 118(11):1997-2004. PubMed ID: 37141541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of colorectal cancer in patients with ulcerative colitis.
    Nowacki TM; Brückner M; Eveslage M; Tepasse P; Pott F; Thoennissen NH; Hengst K; Ross M; Bettenworth D
    Dig Dis Sci; 2015 Feb; 60(2):492-501. PubMed ID: 25280558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
    Feagan BG; Sandborn WJ; Lazar A; Thakkar RB; Huang B; Reilly N; Chen N; Yang M; Skup M; Mulani P; Chao J
    Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
    Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
    J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population-based study of incident cases between 1989-2009.
    Chhaya V; Saxena S; Cecil E; Chatu S; Subramanian V; Curcin V; Majeed A; Pollok RC
    Aliment Pharmacol Ther; 2015 Jan; 41(1):87-98. PubMed ID: 25382737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of pneumonia among patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease.
    Shah R; Richardson P; Yu H; Kramer J; Hou JK
    Digestion; 2017; 95(3):188-193. PubMed ID: 28288458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.
    Krauthammer A; Tzivinikos C; Assa A; Miele E; Strisciuglio C; Urlep D; Serban ED; Singh A; Winter HS; Russell RK; Hojsak I; Malham M; Navas-López VM; Croft NM; Lee HM; Ledder O; Shamasneh I; Hussey S; Huynh HQ; Wine E; Shah N; Sladek M; de Meij TG; Romano C; Dipasquale V; Lionetti P; Afzal NA; Aloi M; Lee K; Martín-de-Carpi J; Yerushalmy-Feler A; Subramanian S; Weiss B; Shouval DS
    J Crohns Colitis; 2019 Dec; 13(12):1518-1526. PubMed ID: 31120524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
    Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
    Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Friedman S; Magnussen B; OʼToole A; Fedder J; Larsen MD; Nørgård BM
    Am J Gastroenterol; 2018 Sep; 113(9):1355. PubMed ID: 29988041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study.
    Eriksson C; Rundquist S; Cao Y; Montgomery S; Halfvarson J
    Gut; 2019 Apr; 68(4):623-632. PubMed ID: 29618498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.
    Safroneeva E; Vavricka SR; Fournier N; Straumann A; Rogler G; Schoepfer AM
    Inflamm Bowel Dis; 2015 Jun; 21(6):1348-58. PubMed ID: 25806845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.